Claims-based proxies of patient instability among commercially insured adults with schizophrenia
Charles Ruetsch,1 Hyong Un,2 Heidi C Waters3 1Health Analytics, LLC, Columbia, MD, USA; 2Aetna, Inc, Blue Bell, PA, USA; 3Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA Objective: Schizophrenia (Sz) patients are among the highest utilizers of hospital-based s...
Main Authors: | Ruetsch C, Un H, Waters HC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-05-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/claims-based-proxies-of-patient-instability-among-commercially-insured-peer-reviewed-article-CEOR |
Similar Items
-
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis
by: Li G, et al.
Published: (2021-10-01) -
Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
by: Alex Z. Fu, et al.
Published: (2022-04-01) -
Polypharmacy and relapse of schizophrenia: are they related?
by: R. Softic, et al.
Published: (2022-06-01) -
Potential of Health Insurance Claims Data to Predict Fractures in Older Adults: A Prospective Cohort Study
by: Reinold J, et al.
Published: (2022-10-01) -
Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database
by: Izumi Kawachi, et al.
Published: (2019-12-01)